Autopsy report · NCT03617380

PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

“transferred to different institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

University of California, San Diego

Sponsor type

University, hospital or other

Conditions

Disease, Chronic

Interventions

Usual Care; PharmD TOC

Participants

0

Trials that died the same way

• Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
  “moved to new institution” (75% match in meaning)
• Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure
  “PI transferred to a new institution” (70% match in meaning)
• ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care
  “PI is in process of transferring to a new institution” (66% match in meaning)
• Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome
  “Principal Investigator has transferred to another Institution” (64% match in meaning)
• Complex Spine Enhanced Recovery After Surgery (ERAS)
  “PI moved to different institution” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.